- Home
- GBTG vs PTGX Comparison
GBTG vs PTGX Comparison
Compare GBTG & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBTG
- PTGX
- Stock Information
- Founded
- GBTG 2014
- PTGX 2006
- Country
- GBTG United States
- PTGX United States
- Employees
- GBTG N/A
- PTGX 130
- Industry
- GBTG Computer Software: Prepackaged Software
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- GBTG Technology
- PTGX Health Care
- Exchange
- GBTG Nasdaq
- PTGX Nasdaq
- Market Cap
- GBTG 4.3B
- PTGX 5.0B
- IPO Year
- GBTG N/A
- PTGX 2016
- Fundamental
- Price
- GBTG $8.00
- PTGX $79.54
- Analyst Decision
- GBTG Strong Buy
- PTGX Strong Buy
- Analyst Count
- GBTG 3
- PTGX 9
- Target Price
- GBTG $10.00
- PTGX $86.22
- AVG Volume (30 Days)
- GBTG 1.0M
- PTGX 1.3M
- Earning Date
- GBTG 11-10-2025
- PTGX 11-06-2025
- Dividend Yield
- GBTG N/A
- PTGX N/A
- EPS Growth
- GBTG N/A
- PTGX N/A
- EPS
- GBTG N/A
- PTGX 0.72
- Revenue
- GBTG $2,440,000,000.00
- PTGX $209,217,000.00
- Revenue This Year
- GBTG $4.42
- PTGX N/A
- Revenue Next Year
- GBTG $4.47
- PTGX $140.23
- P/E Ratio
- GBTG N/A
- PTGX $110.77
- Revenue Growth
- GBTG 3.61
- PTGX N/A
- 52 Week Low
- GBTG $5.78
- PTGX $33.31
- 52 Week High
- GBTG $9.60
- PTGX $93.25
- Technical
- Relative Strength Index (RSI)
- GBTG 51.14
- PTGX 62.21
- Support Level
- GBTG $7.53
- PTGX $75.44
- Resistance Level
- GBTG $8.00
- PTGX $80.43
- Average True Range (ATR)
- GBTG 0.21
- PTGX 2.61
- MACD
- GBTG -0.01
- PTGX -0.23
- Stochastic Oscillator
- GBTG 60.00
- PTGX 89.38
About GBTG Global Business Travel Group Inc.
Global Business Travel Group Inc operates as a business-to-business travel platform. It is engaged in providing software and services to manage travel, expenses, and meetings and events for companies of all sizes. The company is engaged in building the marketplace in B2B travel to deliver unrivaled choice, value, and experiences. It also provides business travel solutions, simplified travel management, and business consulting services. Further, The company generates revenue in two ways that involves fees and other revenues relating to processing and servicing travel transactions received from clients and travel suppliers and revenues for the provision of products and professional services not directly related to transactions received from clients, travel suppliers and Network Partners.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.